Stockreport

Palisade Bio Announces Exercise of Previously Issued Warrants for $2.5 Million

Palisade Bio, Inc.  (PALI) 
PDF Carlsbad, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.  (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing nov [Read more]